With sales of Yaz and Yasmin birth control dropping and Bayer spending over $1 billion to settle claims that the drugs caused dangerous blood clot conditions, the company is making moves to maintain its place in the birth control market.
For years, health experts have warned that contraceptives which contain the hormone drospirenone, such as Yaz and Yasmin, can bring higher risks for blood clots.
These can lead to dangerous and even fatal conditions like deep vein thrombosis (DVT), pulmonary embolism or stroke.
Last year, Bayer reported that sales of the popular drugs had fallen, perhaps due to the warnings. Also, more than 13,000 women have now filed a Yaz lawsuit for side effects or injuries such as blood clots.
With cases swelling in a special federal drug injury court, Bayer began settling them in early 2012. The latest reports show the company has spent nearly $1 billion to settle around 5,000 cases, and has set aside more funds for those still coming.
Now, Bayer has purchased the California-based Conceptus Pharmaceuticals in order to obtain the rights to the Essure birth control device. Already used by over 750,000 women around the world, Bayer hopes to increase sales of the brand.
Essure is a permanent type of birth control which is implanted by a patient’s doctor in a 10-minute procedure. Two small metal coil inserts implanted through the cervix block the fallopian tubes and prevent pregnancy.
Time will show whether Essure has any of the side effects of Bayer’s other birth control products, Yaz, Yasmin and Mirena. For now, lawyers are still helping those affected by blood clots after taking Yaz or Yasmin file claims for a settlement. However, it is important to speak with a lawyer as soon as possible as time is limited.
DrugRisk only recommends lawyers and law firms who have already settled Yaz lawsuits. For more information on Yaz blood clots, or to speak with a lawyer, contact us today.